The company recorded $3.5 billion sales from the drug in the first half of 2021 and recently signed a $2.94 billion contract with the U.S. Regeneron’s cocktail, REGEN-COV, is taking the lion’s share of the current market. RELATED: Merck makes beeline to FDA, seeking approval for COVID-19 antiviral 10 days after reporting dataĪt the current run rate, the Department of Health and Human Services will need to ship 4.9 million doses of antibody drugs to meet demand over the next six months, but the existing contract only covers 2.7 million, leaving a “supply gap” of 2.2 million doses for the next six months alone, Porges noted. To Porges, this suggests “antibodies are finally being incorporated into routine treatment practices and protocols.” Over the next six to 12 months, supply of COVID antibodies will still be constrained, he estimated. Department of Health and Human Services suggest an average 190,000 doses of COVID antibodies each week despite a recent decrease in new COVID cases.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |